What is the regional analysis of Oligonucleotide Pool Market?
Oligonucleotide
Pool Market Highlights:
Biotechnological
advancements and healthcare sector are in a cumulative effort are paving the
way for oligonucleotide pool to have significant growth. Oligonucleotides have
become an essential component for synthesizing DNA and RNA. They gain much
precedence in DNA sequencing and amplification, various mutations and for the
synthesis of artificial genes.
The Oligonucleotide Pool Market size is estimated to grow at a CAGR of 10.3%. As a
result, the market value will further register up to USD 2,562.6 Million by the
end of the forecast period 2021-2028, reveals Market Research Future (MRFR) in
an extensive study. The report encompasses various drivers that are also going
to boost the market significantly during the same period. Driver list includes
big pharmacies investing considerable sum in the market, contract manufacturing
organizations (CMO) actively getting involved in decision making, and
governments taking a keen interest in the market.
However,
the number of approved oligonucleotide drugs in the U.S. is very small which
can play as a market irritant. But researchers have already developed many that
are awaiting clinical trials and once approved, can change the market scenario
considerably.
Segmentation:
The custom oligonucleotides pool market can be segmented by types,
application, and end-users.
By
type, the market can be segmented into DNA pool and RNA pool.
Based
on application the market is segmented into research, diagnostics &
therapeutics, and others.
Based
on end-users the market is segmented into commercial research, pure academic
research and others.
Regional
Analysis:
Region-specific
oligonucleotide pool market outlook can be segmented namely North America, Europe,
Asia Pacific (APAC), and the Middle East & Africa (MEA).
North
America has the largest market share as the region has superior infrastructure
to support both biotechnological and pharmaceutical research. Governments and
private investors both are showing substantial interest in this sector which is
bolstering the growth of the industry in this region. At the same time, the
region has a huge patient pool suffering from chronic diseases which are
further fuelling the need for pharmaceutical innovation. It can expect a CAGR
of 8.6% during the forecast period.
Europe
is also enjoying similar features like North America which have made it
possible for the region to assume the second spot. Presence of several market
leaders in the region is expected to ensure its projected CAGR of 8.7% during
the review period. The APAC is touted to register the fastest CAGR during the
forecast period with emerging economies such as India and China investing
considerably in the biotechnological sector. However, infrastructural
inferiority is going to put a leash on the growth of the MEA region which is
going to enjoy only a steady increase.
Oligonucleotide Pool Market Players
The global oligonucleotide
pool market
players are Agilent Technologies, Creative Biogene, CustomArray, Inc,
Integrated DNA Technologies, Inc., MYcroarray, Sigma Aldrich, TriLink
BioTechnologies, Twist Bioscience, and others.
About Market
Research Future:
At Market Research
Future (MRFR), we enable our customers to unravel the complexity of various
industries through our Cooked Research Report (CRR), Half-Cooked Research
Reports (HCRR), & Consulting Services. MRFR team have supreme objective to
provide the optimum quality market research and intelligence services to our
clients.
Contact us:
Market Research Future
(part of Wantstats Research and Media Private Limited),
99 Hudson Street,
5Th Floor,
New York, New York
10013
United States of
America
+1 628 258 0071
Email: sales@marketresearchfuture.com
Comments
Post a Comment